HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

destruxin E2 chlorohydrin

isolated from Metarrhizium anisopliae; structure given in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Depsipeptides: 297
      - destruxin E2 chlorohydrin: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Depsipeptides: 297
      - destruxin E2 chlorohydrin: 1

Experts

1.	Amagata, Taro: 1 article (09/2007)
2.	Boot, Claudia M: 1 article (09/2007)
3.	Compton, Jennifer E: 1 article (09/2007)
4.	Crews, Phillip: 1 article (09/2007)
5.	Pietraszkiewicz, Halina: 1 article (09/2007)
6.	Tenney, Karen: 1 article (09/2007)
7.	Valeriote, Frederick A: 1 article (09/2007)

Related Diseases

1.	Neoplasms (Cancer) 09/24/2007 - "An initial therapeutic assessment suggested a continuous (168 h) exposure of at least 2 ng/ml, or a daily (24 h) exposure of at least 300 ng/ml for H125 cells treated with efrapeptin G, and a continuous (168 h) exposure of at least 190 ng/ml for HCT-116 cells treated with destruxin E2 chlorohydrin, will cause 90% tumor cell death in vitro."

Related Drugs and Biologics

1.	efrapeptin G